Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimen.

Expert opinion on drug metabolism & toxicology - 1 Jan 2000

Liang Jiayi, Ringeling Lisa T, Hermans Rebecca A, Bayraktar Izgi, Bosch Tessa M, Egberts Karin M, Kloosterboer Sanne M, de Winter Brenda, Dierckx Bram, Koch Birgit C P

Abstract excerpt

INTRODUCTION: Achieving optimal clinical responses and minimizing side effects through precision dosing of antipsychotics in children and adolescents with psychiatric disorders remains a challenge. Identifying patient characteristics (covariates) that affect pharmacokinetics can inform more effective dosing strategies and ultimately improve patient outcomes. This review aims to provide greater insight into the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mental Disorders

Share to Phenotype

Source

Identifiers

PMID: 37668177
DOI: 10.1080/17425255.2023.2252340

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical pharmacokinetics of antipsychotics in pediatric populations: a scoping review focusing on dosing regimen.PMID 37668177Read ↗

Individualizing the use of medications in children: making Goldilocks happy.Semantic proximity Read ↗

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

ADHD pharmacogenetics across the life cycle: New findings and perspectivesSemantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic TreatmentsSemantic proximity Read ↗

Personalizing Atomoxetine Dosing in Children with ADHD: What Can We Learn from Current Supporting EvidenceSemantic proximity Read ↗

Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Semantic proximity Read ↗

Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Semantic proximity Read ↗

Pharmacogenetics of antipsychotics: recent progress and methodological issuesSemantic proximity Read ↗

Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.Semantic proximity Read ↗

The Implications of Cytochrome P450 2D6/CYP2D6 Polymorphism in the Therapeutic Response of Atypical Antipsychotics in Adolescents with Psychosis—A Prospective StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.